ECONOMIC EVALUATION OF LENALIDOMIDE IN THE TREATMENT OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH DEL5Q (MDS DEL5Q) IN MEXICO
Abstract
Authors
C. Ramos E. Montaño A. Reyes Lopez I. Pacheco-Alvarez G. Hernandez-Rivera E.A. Lemus-Carmona